How biotechs can tap APAC for excellence in oncology trials
Focus:
-
![Virtual trials: welcome to the present]()
Virtual trials: welcome to the present
-
![Why Asia-Pacific attracts 60% of all ongoing and planned hepatology trials globally]()
Why Asia-Pacific attracts 60% of all ongoing and planned hepatology trials globally
-
![The impact of Covid-19 on the global clinical supply chain]()
The impact of Covid-19 on the global clinical supply chain
-
![Covid-19 drug studies could highlight speed, flexibility and reduced risk of virtual clinical trials]()
Covid-19 drug studies could highlight speed, flexibility and reduced risk of virtual clinical trials
-
![Alexander O’Leary Q&A: how are clinical trial sponsors’ outsourcing activities evolving?]()
Alexander O’Leary Q&A: how are clinical trial sponsors’ outsourcing activities evolving?
-
![A closer look at Regeneron and its efforts to provide the world with a Covid-19 treatment]()
A closer look at Regeneron and its efforts to provide the world with a Covid-19 treatment
-
A science lesson in secure investing
Expert commentary & analysis from GlobalData
Increased Development of Targeted Therapies in the Neuroendocrine Tumors Pipeline Promises a Shift in the Standard of Care
Disruptions to global oncology trials have fallen to a three-month low
Abivax’s ABX464 enticing in theory for Covid-19 but mechanism, trial design issues belie potential for success
AstraZeneca/Amgen’s Phase III tezepelumab potential to expand to noneosinopilic asthma patients backed by early data and MOA but caution remains
Most Read
Company releases
Viedoc eClinical Suite – Logistics
Trial supply management for optimised inventory.
Viedoc eClinical Suite – Me
Viedoc eClinical Suite – Designer
Professional study build and libraries tailored to you.
Viedoc eClinical Suite – Admin
Viedoc eClinical Suite – Clinic
Data collection and monitoring made easy.
Company whitepapers
Inspection Readiness When Working in Viedoc
Viedoc TechnologiesTrehalose: A Powerful Excipient in the Formulation Toolbox
PfanstiehlPatented Extracts, Amino Acids and Enzymes for Manufacturing Natural Plant-Based Products
Laboratorios Planes (PLANtas ESpañolas)Study: Pharmacokinetics of Oral Cyanocobalamin Formulated with SNAC
Emisphere TechnologiesDefeating the Spread of Covid-19 with Laboratory Equipment from IKA
Ika-WerkeData Logging and Real-Time Piece Visibility for Life Sciences and Pharmaceutical Products in the Supply Chain
OnAsset IntelligenceIoT Tracking and Monitoring
OnAsset IntelligenceCompany A-Z
Clinical Trials
Imara begins dosing in Phase IIb sickle cell disease trial
Biopharmaceutical firm Imara has started dosing patients in the Phase IIb Ardent clinical trial of IMR-687 to treat adults with sickle cell disease (SCD).
University of Minnesota trials stem cell therapy for Covid-19
Novo Nordisk to restart Phase III haemophilia trials of concizumab
New Series B financing enables Reify Health to integrate trials
FDA accepts Enzychem’s application for Covid-19 trial
Drug Development
Imara begins dosing in Phase IIb sickle cell disease trial
Biopharmaceutical firm Imara has started dosing patients in the Phase IIb Ardent clinical trial of IMR-687 to treat adults with sickle cell disease (SCD).
University of Minnesota trials stem cell therapy for Covid-19
Novo Nordisk to restart Phase III haemophilia trials of concizumab
FDA accepts Enzychem’s application for Covid-19 trial
Boehringer starts enrolment for paediatric trial of nintedanib
Your recommended content
Why we believe workplace health and wellness is important
Download a free 10 page preview of our Mergers & Acquisitions in TMT – Thematic Research 2019 Report
Accelerating Clinical Trials: Your recommended content
Clinical Trial Continuity in Asia-Pacific during the COVID-19 pandemic
Future of Mining: Your recommended content
A sneak peek into Canada’s largest transit expansion
Precision medical wire: Your recommended content
Precision wire for vascular therapy: How EXERA® rises to the challenge
Go Top